Aeglea BioTherapeutics, Inc. (Nasdaq: AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

Aeglea BioTherapeutics (AGLE) Prices 3.75M Share Common Offering at $8/Sh and Prices 3.75M Warrant Offering at $7.99/UnitFebruary 6, 2019 5:48 AM Aeglea BioTherapeutics Announces Proposed Public Offering of Common StockFebruary 5, 2019 5:15 PM